ConforMIS Inc (CFMS) Tops Q2 EPS by 8c, FY Revenue Guidance Misses Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance
August 3, 2017 4:05 PM EDTBILLERICA, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2017.
Q2 Summary:
Total revenue of $18.5 million, down 4.4% year-over-year on a reported basis and down 3.6% on a constant currency basisProduct revenue of $18.0 million, down 5.5% year-over-year on a reported basis and down 4.8% on a constant currency basis-... More